(19)
(11) EP 1 112 361 A2

(12)

(88) Date of publication A3:
21.09.2000

(43) Date of publication:
04.07.2001 Bulletin 2001/27

(21) Application number: 99946891.1

(22) Date of filing: 13.09.1999
(51) International Patent Classification (IPC)7C12N 15/12, C07K 14/47, A61K 38/17, G01N 33/50, C12Q 1/68, C07K 16/18, A61K 31/70
(86) International application number:
PCT/US9920/944
(87) International publication number:
WO 0015/792 (23.03.2000 Gazette 2000/12)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 14.09.1998 US 100262 P
14.09.1998 WO PCT/US98/19177

(71) Applicant: Genentech, Inc.
South San Francisco, CA 94080-4990 (US)

(72) Inventors:
  • FONG, Sherman
    Alameda, CA 94502 (US)
  • GERRITSEN, Mary, E.
    San Mateo, CA 94402 (US)
  • GODDARD, Audrey
    San Francisco, CA 94131 (US)
  • GURNEY, Austin, L.
    Belmont, CA 94002 (US)
  • HILLAN, Kenneth, J.
    San Francisco, CA 94114 (US)
  • WILLIAMS, P., Mickey
    Half Moon Bay, CA 94019 (US)
  • WOOD, William, I.
    Hillsborough, CA 94010 (US)

(74) Representative: Denison, Christopher Marcus et al
Mewburn EllisYork House23 Kingsway
GB-London WC2B 6HP
GB-London WC2B 6HP (GB)

   


(54) PROMOTION OR INHIBITION OF ANGIOGENESIS AND CARDIOVASCULARIZATION